A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection
Clinical trial NCT00000652 · COMPLETED
Trial details
- NCT number
- NCT00000652
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.